$Voyager Therapeutics(VYGR)$Voyager Therapeutics Inc has risen 45.45% over the past month, closing at $3.25 on September 14. During this period of time, the stock fell as low as $2.47 and as high as $5.73. VYGR has an average analyst recommendation of Buy. The company has an average price target of $6.36
$Voyager Therapeutics(VYGR)$today market cap at $140mil.Pfizer had licensed access to its gene therapy technology in a deal worth up to $630 million.What's the price target if this deal go on?